EHMT2 and non-small cell lung carcinoma: In order to test this hypothesis, we determined ALDH2 protein levels in NSCLC/PTX cells treated with three other EHMT2 inhibitors (UNC0638, UNC0642, UNC0631) and the JMJD inhibitor JIB04.